Your browser doesn't support javascript.
loading
First international workshop of the ATM and cancer risk group (4-5 December 2019).
Lesueur, Fabienne; Easton, Douglas F; Renault, Anne-Laure; Tavtigian, Sean V; Bernstein, Jonine L; Kote-Jarai, Zsofia; Eeles, Rosalind A; Plaseska-Karanfia, Dijana; Feliubadaló, Lidia; Arun, Banu; Herold, Natalie; Versmold, Beatrix; Schmutzler, Rita Katharina; Nguyen-Dumont, Tú; Southey, Melissa C; Dorling, Leila; Dunning, Alison M; Ghiorzo, Paola; Dalmasso, Bruna Samia; Cavaciuti, Eve; Le Gal, Dorothée; Roberts, Nicholas J; Dominguez-Valentin, Mev; Rookus, Matti; Taylor, Alexander M R; Goldstein, Alisa M; Goldgar, David E; Stoppa-Lyonnet, Dominique; Andrieu, Nadine.
Afiliación
  • Lesueur F; Genetic Epidemiology of Cancer Team, INSERM U900, Institut Curie, 26 rue d'Ulm, 75005, Paris, France.
  • Easton DF; Institut Curie, Paris, France.
  • Renault AL; Mines ParisTech, Fontainebleau, France.
  • Tavtigian SV; PSL Research University, Paris, France.
  • Bernstein JL; Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
  • Kote-Jarai Z; Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
  • Eeles RA; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Plaseska-Karanfia D; Huntsman Cancer Institute, Salt Lake City, USA.
  • Feliubadaló L; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Arun B; The Institute of Cancer Research, London, UK.
  • Herold N; Research Centre for Genetic Engineering and Biotechnology « Georgi D. Efremov ¼, MASA, Skopje, UK.
  • Versmold B; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Schmutzler RK; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Nguyen-Dumont T; University of Texas MD Anderson Cancer Center, Houston, USA.
  • Southey MC; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Dorling L; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Dunning AM; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Dalmasso BS; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Cavaciuti E; Cancer Epidemiology Division, Cancer Council Victoria, Victoria, 3004, Australia.
  • Le Gal D; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Roberts NJ; Cancer Epidemiology Division, Cancer Council Victoria, Victoria, 3004, Australia.
  • Dominguez-Valentin M; Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
  • Rookus M; Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
  • Taylor AMR; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Goldstein AM; Genetics of Rare Cancers, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
  • Goldgar DE; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Stoppa-Lyonnet D; Genetic Epidemiology of Cancer Team, INSERM U900, Institut Curie, 26 rue d'Ulm, 75005, Paris, France.
  • Andrieu N; Institut Curie, Paris, France.
Fam Cancer ; 21(2): 211-227, 2022 04.
Article en En | MEDLINE | ID: mdl-34125377
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ataxia Telangiectasia / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ataxia Telangiectasia / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos